Growth Company Investor - Stock market recommendations on AIM and small cap companies

23 May 2013

Popular Topics within cash

Oxford BioMedica seeks partners 24/08/2010

Out-of-favour Oxford BioMedica is seeking partners to develop two gene therapies after interim losses up 177 per cent to £3.6 million.

Tags: Cash, Deals & contracts, Full list

Hardy shrinks first-half loss 19/08/2010

India-focused Hardy Oil and Gas is pursuing expansion after cutting interim losses 76 per cent to $1.35 million (£860,000).

Tags: Cash, Full list

Profits leap at Scientific Digital 19/07/2010

Scientific Digital Imaging remains acquisitive after lifting annual pre-tax profits more than fourfold to £258,000.

Tags: AIM, Boardroom moves, Cash, Growth Stocks

Zoo Digital wins US backing
02/07/2010

New York-headquartered Multi Packaging Solutions (MPS) is to pay £859,456 for 9.1 per cent of AIM-quoted entertainment software and services provider Zoo Digital, with warrants to double that stake as part of a new strategic relationship between the two companies.

Tags: AIM, Cash, Deals & contracts, Growth Stocks

Turnaround at Falkland Islands  23/06/2010

Falkland Island Holdings (FIH) has turned £627,000 annual losses into £5.7 million pre-tax profits and awaits imminent oil drilling results.

Tags: AIM, Cash, Dividend, Turnaround

Interim profits soar at Gooch 08/06/2010

Optical components and systems manufacturer Gooch & Housego saw pre-tax profits surge from £39,000 to £1.7 million in the half-year to March.

Tags: AIM, Cash, Growth Stocks

Young's cheers with profits push 03/06/2010

AIM-quoted pubs operator Young & Co's Brewery has buoyed investors' spirits with positive profits progression in a challenging year to March.

Tags: AIM, Cash, Growth Stocks

Profits slip at Hamworthy 02/06/2010

AIM-listed marine fluid-handling systems specialist Hamworthy has announced a dip in profits for the year to March.

Tags: AIM, Cash, Deals & contracts, Dividend

Renovo moots cosmetic deal 20/05/2010

Biopharmaceutical specialist Renovo is discussing potential cosmetic uses for its Juvidex wound-healing product after trimming interim losses.

Tags: Cash, Deals & contracts, Full list, Restructuring

Licence fees boost ImmuPharma 19/05/2010

Drug discoverer ImmuPharma has lifted annual pre-tax profits 85 per cent to £9.1 million after a £21 million licence payment.

Tags: AIM, Cash, Deals & contracts

Strategic Thought cuts deficit 12/05/2010

Risk management software developer Strategic Thought has reduced losses from £2.1 million to £767,000 on buoyant turnover. 

Tags: AIM, Cash, Deals & contracts, Growth Stocks

Losses double at Southern Cross 11/05/2010

Southern Cross Healthcare Group is pinning hopes on its 'New Horizons' recovery policy after nearly doubling interim losses to £22.9 million.

Tags: Boardroom moves, Cash, Full list

Forward Thinking Communications

FWD is a strategic communications agency specialising in corporate & financial services in the UK, across Europe and into Asia. We understand financial markets inside out. We know who you want to talk to. And we know the type of messages they want to hear. Find out more.

The latest company webcasts

Live and pre recorded video & audio updates from companies on their latest news, results & AGMs through interviews and presentations. Find out more.

The Share Centre

Stocks & Shares ISA

Onine Tools To Make Investments

Easy And Low Admin Fee

Achieve impressive returns on the go

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!

Chair and Non-Executive Director Guidelines

Chris Spencer-Phillips, MD of First Flight Non-Executive Directors and ShareSoc - www.sharesoc.org the UK Individual Shareholders Society have developed a set of guidelines covering the search, selection and remuneration of Chairs and Non-Executive Directors. Download the Non Executive Guidelines .

Cash Shells 2013

This research provides a comprehensive overview of cash shells, companies that have become a significant feature on the Main Market, AIM and PLUS landscape. The full report (out June 2013) is now available to pre-order in PDF format for £295 (+VAT). Contact us for more info

Director's Pay 2013

The annual Directors' Pay on AIM Report is the most comprehensive review of directors' renumeration on AIM available. It's ideal for benchmarking your team's, your organisation's and your own salary. The full report is available to order in PDF format for £350 (+VAT). Order report here

M&A on AIM 2012

This new report examines valuation metrics, cash balances and financial performance to provide dealmakers with all the tools they need to pinpoint undervalued companies on AIM. The full report is available to order in PDF format for £295 (+VAT). Order report here

Coverage and tips for AIM and Small Caps

Informative features and research on fast-growing companies, with AIM market and small cap tips, news on growth stocks, penny shares and junior stock market companies. Regular share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

If you're interested in business tax updates visit our specialist tax guide website.

Your Financial Recovery Starts here

For great ideas on how to invigorate your portfolio visit the Growth Company Investor Show on June 10th. Click here for more details.

Popular Topics